Keybank National Association Novo Nordisk A S Transaction History

Keybank National Association

  • $24.5 Billion
  • Q1 2025

A detailed history of Keybank National Association transactions in Novo Nordisk A S stock. As of the latest transaction made, Keybank National Association holds 59,775 shares of NVO stock, worth $4.03 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
59,775
Previous 66,497 10.11%
Holding current value
$4.03 Million
Previous $5.72 Million 27.45%
% of portfolio
0.02%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025
SELL
$69.3 - $90.95 $465,834 - $611,365
-6,722 Reduced 10.11%
59,775 $4.15 Million
Q4 2024

Feb 06, 2025
BUY
$85.0 - $120.04 $85,595 - $120,880
1,007 Added 1.54%
66,497 $5.72 Million
Q3 2024

Oct 31, 2024
BUY
$119.07 - $145.42 $772,645 - $943,630
6,489 Added 11.0%
65,490 $7.8 Million
Q2 2024

Jul 31, 2024
BUY
$122.71 - $146.91 $166,517 - $199,356
1,357 Added 2.35%
59,001 $8.42 Million
Q1 2024

May 14, 2024
SELL
$102.11 - $135.92 $103,335 - $137,551
-1,012 Reduced 1.73%
57,644 $7.4 Million
Q4 2023

Feb 13, 2024
SELL
$87.78 - $105.45 $62,499 - $75,080
-712 Reduced 1.2%
58,656 $6.07 Million
Q3 2023

Nov 08, 2023
BUY
$90.94 - $199.54 $2.7 Million - $5.93 Million
29,722 Added 100.26%
59,368 $5.4 Million
Q2 2023

Aug 01, 2023
BUY
$155.98 - $172.65 $31,195 - $34,530
200 Added 0.68%
29,646 $4.8 Million
Q1 2023

May 10, 2023
BUY
$132.34 - $159.14 $105,872 - $127,311
800 Added 2.79%
29,446 $4.69 Million
Q4 2022

Jan 31, 2023
BUY
$102.55 - $135.33 $116,394 - $153,599
1,135 Added 4.13%
28,646 $3.88 Million
Q3 2022

Oct 27, 2022
BUY
$95.28 - $116.93 $262,496 - $322,142
2,755 Added 11.13%
27,511 $2.74 Million
Q2 2022

Aug 08, 2022
SELL
$103.24 - $121.81 $72,577 - $85,632
-703 Reduced 2.76%
24,756 $2.76 Million
Q1 2022

Apr 28, 2022
SELL
$93.1 - $112.54 $23,647 - $28,585
-254 Reduced 0.99%
25,459 $2.83 Million
Q4 2021

Feb 07, 2022
BUY
$95.88 - $117.08 $67,211 - $82,073
701 Added 2.8%
25,713 $2.88 Million
Q3 2021

Nov 08, 2021
BUY
$84.42 - $106.62 $10,805 - $13,647
128 Added 0.51%
25,012 $2.4 Million
Q2 2021

Aug 12, 2021
BUY
$67.66 - $84.76 $51,692 - $64,756
764 Added 3.17%
24,884 $2.09 Million
Q1 2021

May 07, 2021
BUY
$67.06 - $75.82 $313,371 - $354,306
4,673 Added 24.03%
24,120 $1.63 Million
Q4 2020

Feb 09, 2021
BUY
$63.89 - $73.8 $255 - $295
4 Added 0.02%
19,447 $1.36 Million
Q3 2020

Oct 29, 2020
BUY
$63.69 - $70.22 $14,839 - $16,361
233 Added 1.21%
19,443 $1.35 Million
Q2 2020

Aug 10, 2020
BUY
$58.54 - $67.94 $292 - $339
5 Added 0.03%
19,210 $1.26 Million
Q1 2020

May 13, 2020
SELL
$49.46 - $64.78 $2,275 - $2,979
-46 Reduced 0.24%
19,205 $1.16 Million
Q4 2019

Feb 05, 2020
BUY
$49.86 - $58.26 $214,697 - $250,867
4,306 Added 28.81%
19,251 $1.11 Million
Q3 2019

Nov 04, 2019
SELL
$47.54 - $53.43 $5,657 - $6,358
-119 Reduced 0.79%
14,945 $773,000
Q2 2019

Aug 01, 2019
BUY
$46.79 - $52.47 $323,365 - $362,620
6,911 Added 84.77%
15,064 $769,000
Q1 2019

May 08, 2019
BUY
$46.36 - $52.63 $39,498 - $44,840
852 Added 11.67%
8,153 $426,000
Q4 2018

Jan 30, 2019
SELL
$41.54 - $47.25 $50,304 - $57,219
-1,211 Reduced 14.23%
7,301 $336,000
Q3 2018

Nov 08, 2018
BUY
$46.76 - $51.24 $10,754 - $11,785
230 Added 2.78%
8,512 $401,000
Q1 2018

May 15, 2018
SELL
$48.49 - $58.14 $40,489 - $48,546
-835 Reduced 9.16%
8,282 $408,000
Q4 2017

Feb 08, 2018
BUY
$47.53 - $53.73 $11,026 - $12,465
232 Added 2.61%
9,117 $489,000
Q3 2017

Nov 02, 2017
BUY
$41.15 - $49.22 $17,900 - $21,410
435 Added 5.15%
8,885 $428,000
Q2 2017

May 14, 2018
SELL
N/A
-3,721 Reduced 30.57%
8,450 $362,000
Q1 2017

May 14, 2018
SELL
N/A
-1,584 Reduced 11.52%
12,171 $417,000
Q4 2016

May 14, 2018
BUY
N/A
13,755
13,755 $493,000

Others Institutions Holding NVO

# of Institutions
1,768
Shares Held
330M
Call Options Held
11.3M
Put Options Held
15.5M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $152B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email